Final Device Labeling Guidance To Include More Flexible HLI Section
This article was originally published in The Gray Sheet
FDA's final device labeling guidance will provide less prescriptive recommendations on "highlights of labeling information" (HLI), according to agency staffers. The final guidance is slated to be released on the FDA Center for Devices and Radiological Health's web page around March 15.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake - but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.